Construction engineering in China has different architectural characteristics in different periods. At present, the research and innovation of building materials and building technology is causing increasing uncertain...Construction engineering in China has different architectural characteristics in different periods. At present, the research and innovation of building materials and building technology is causing increasing uncertainty to architecture. It is necessary to solve the existing problems through construction management and strengthen the supervision of all aspects. The content of the building is quite complex, the construction cycle is long, the technology, materials and equipment used have different characteristics, the staff must be truly integrated into the construction site, technical inspection and quality acceptance. Although the importance of the construction site management is obvious, due to personnel and other factors, the site management can not be effectively operated during the actual construction. Relevant personnel can carry on the thorough study and discussion to it in the ground construction site.展开更多
目的比较成人和儿童乙型脑炎减毒活疫苗(Japanese encephalitis attenuated live vaccine,JE-L)预防接种不良反应发生率。方法通过中国和甘肃省免疫规划信息管理系统收集甘肃省2019-2020年JE-L预防接种不良反应个案和接种信息,比较40-7...目的比较成人和儿童乙型脑炎减毒活疫苗(Japanese encephalitis attenuated live vaccine,JE-L)预防接种不良反应发生率。方法通过中国和甘肃省免疫规划信息管理系统收集甘肃省2019-2020年JE-L预防接种不良反应个案和接种信息,比较40-74岁成人和0-14岁儿童JE-L不良反应报告发生率。结果甘肃省2019-2020年40-74岁成人、0-14岁儿童JE-L预防接种不良反应报告发生率分别为19.89/10万剂(81例)、214.14/10万剂(2798例)(RR=0.09,95%CI:0.07-0.12);其中一般反应分别为19.89/10万剂(81例)、213.99/10万剂(2796例),异常反应分别为0.00/10万剂、0.15/10万剂(2例)。结论JE-L预防接种不良反应发生率在可接受范围内,且多为轻微反应;成人不良反应发生率低于儿童。展开更多
目的评价适龄儿童肠道病毒71型(Enterovirus type 71,EV71)灭活疫苗预防接种后不良反应发生率。方法通过中国疑似预防接种异常反应监测信息管理系统收集甘肃省2017-2021年6-71月龄儿童EV71疫苗不良反应个案,估算一般反应和异常反应报告...目的评价适龄儿童肠道病毒71型(Enterovirus type 71,EV71)灭活疫苗预防接种后不良反应发生率。方法通过中国疑似预防接种异常反应监测信息管理系统收集甘肃省2017-2021年6-71月龄儿童EV71疫苗不良反应个案,估算一般反应和异常反应报告发生率。结果甘肃省2017-2021年儿童接种EV71疫苗后一般反应、异常反应报告发生率分别为70.14/10万(447例)、0.31/10万(2例);其中注射部位红肿、硬结分别为7.22/10万、2.35/10万,发热、食欲下降、乏力/嗜睡、恶心/呕吐、腹泻等全身反应分别为57.75/10万、7.53/10万、6.43/10万、5.81/10万、5.18/10万;热性惊厥、过敏性紫癜均为0.16/10万。结论甘肃省2017-2021年适龄儿童EV71预防接种不良反应发生率在预期范围内,严重反应极为罕见。展开更多
文摘Construction engineering in China has different architectural characteristics in different periods. At present, the research and innovation of building materials and building technology is causing increasing uncertainty to architecture. It is necessary to solve the existing problems through construction management and strengthen the supervision of all aspects. The content of the building is quite complex, the construction cycle is long, the technology, materials and equipment used have different characteristics, the staff must be truly integrated into the construction site, technical inspection and quality acceptance. Although the importance of the construction site management is obvious, due to personnel and other factors, the site management can not be effectively operated during the actual construction. Relevant personnel can carry on the thorough study and discussion to it in the ground construction site.
文摘目的比较成人和儿童乙型脑炎减毒活疫苗(Japanese encephalitis attenuated live vaccine,JE-L)预防接种不良反应发生率。方法通过中国和甘肃省免疫规划信息管理系统收集甘肃省2019-2020年JE-L预防接种不良反应个案和接种信息,比较40-74岁成人和0-14岁儿童JE-L不良反应报告发生率。结果甘肃省2019-2020年40-74岁成人、0-14岁儿童JE-L预防接种不良反应报告发生率分别为19.89/10万剂(81例)、214.14/10万剂(2798例)(RR=0.09,95%CI:0.07-0.12);其中一般反应分别为19.89/10万剂(81例)、213.99/10万剂(2796例),异常反应分别为0.00/10万剂、0.15/10万剂(2例)。结论JE-L预防接种不良反应发生率在可接受范围内,且多为轻微反应;成人不良反应发生率低于儿童。
文摘目的评价适龄儿童肠道病毒71型(Enterovirus type 71,EV71)灭活疫苗预防接种后不良反应发生率。方法通过中国疑似预防接种异常反应监测信息管理系统收集甘肃省2017-2021年6-71月龄儿童EV71疫苗不良反应个案,估算一般反应和异常反应报告发生率。结果甘肃省2017-2021年儿童接种EV71疫苗后一般反应、异常反应报告发生率分别为70.14/10万(447例)、0.31/10万(2例);其中注射部位红肿、硬结分别为7.22/10万、2.35/10万,发热、食欲下降、乏力/嗜睡、恶心/呕吐、腹泻等全身反应分别为57.75/10万、7.53/10万、6.43/10万、5.81/10万、5.18/10万;热性惊厥、过敏性紫癜均为0.16/10万。结论甘肃省2017-2021年适龄儿童EV71预防接种不良反应发生率在预期范围内,严重反应极为罕见。
